Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study.

Flynn DO, Kennedy F, Hughes S, Magill F, McDonnell GV, Black N, Darrat M, Mullan G, Darcy R, McCance DR, et al.

Clin Endocrinol (Oxf). 2026 Aug 13. PMID: 42592679. Abstract